# Constella™(EU)-Linzess™(USA): the last milestone in the long journey of the peptide linaclotide and its implications for the future of peptide drugs.

> PubMed lists PMID 23464519 in Future medicinal chemistry as Journal Article, Research Support, Non-U.S. Gov't, Review, with publication-date metadata of 2013-03 (month precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-23464519-linaclotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2017-11-16
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-23464519-linaclotide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-23464519-linaclotide-v1.json
- Content SHA-256: `ec4ed7e20c28b884fed43bc1a9aae0f2631b91c90f415578737f2d0ef1cf95c4`

## Claims and source pins

### Headline

Constella™(EU)-Linzess™(USA): the last milestone in the long journey of the peptide linaclotide and its implications for the future of peptide drugs. ([`pubmed-observation-pmid-23464519-2017-11-16-99a4fbd8bc87`](#source-pubmed-observation-pmid-23464519-2017-11-16-99a4fbd8bc87))

### Summary

PubMed lists PMID 23464519 in Future medicinal chemistry as Journal Article, Research Support, Non-U.S. Gov't, Review, with publication-date metadata of 2013-03 (month precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-23464519-2017-11-16-99a4fbd8bc87`](#source-pubmed-observation-pmid-23464519-2017-11-16-99a4fbd8bc87))

### Paragraph 1

PubMed lists PMID 23464519 in Future medicinal chemistry as Journal Article, Research Support, Non-U.S. Gov't, Review, with publication-date metadata of 2013-03 (month precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-23464519-2017-11-16-99a4fbd8bc87`](#source-pubmed-observation-pmid-23464519-2017-11-16-99a4fbd8bc87))

### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-23464519-2017-11-16-99a4fbd8bc87`](#source-pubmed-observation-pmid-23464519-2017-11-16-99a4fbd8bc87))

## Sources

<a id="source-pubmed-observation-pmid-23464519-2017-11-16-99a4fbd8bc87"></a>
- **Constella™(EU)-Linzess™(USA): the last milestone in the long journey of the peptide linaclotide and its implications for the future of peptide drugs. · retained source version 1:2017-11-16:current:99a4fbd8bc8711399024168d5fa7fbf10360fbf06bddff99eb54028943c497cf** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/23464519/) (`pubmed-observation-pmid-23464519-2017-11-16-99a4fbd8bc87`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "Constella™(EU)-Linzess™(USA): the last milestone in the long journey of the peptide linaclotide and its implications for the future of peptide drugs." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-23464519-linaclotide-v1.json SHA-256: ec4ed7e20c28b884fed43bc1a9aae0f2631b91c90f415578737f2d0ef1cf95c4.